MobiHealthNews: Eko Health’s AI-Enabled Cardiac Tool Receives FDA Clearance

Posted in Newsroom
Summary: Eko's low ejection fraction tool will be added to the company's cardiac early detection platform, which already includes various algorithms to inspect heart health.
Doctor listening to patient with stethoscope
Digital cardiac and lung disease health startup Eko Health announced it received FDA 510(k) clearance for its AI-enabled cardiac tool that helps with the early detection of low ejection fraction, a key indicator of heart failure.

Eko's Low Ejection Fraction Tool (ELEFT) is an AI-enabled tool that allows providers to detect low ejection fraction in 15 seconds during a routine exam using an Eko stethoscope.

Read more at MobiHealthNews